Toenec Corporation
Toenec Corporation (1946.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Toenec Corporation (1946.T), featuring income statements, balance sheets, and cash flow data.
Toenec Corporation (1946.T) Income Statement & Financial Overview
Explore comprehensive income reports for Toenec Corporation 1946.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $72.65B | $71.47B | $66.87B | $59.98B |
| Cost of Revenue | $60.24B | $61.47B | $57.24B | $51.55B |
| Gross Profit | $12.42B | $10.001B | $9.63B | $8.43B |
| Gross Profit Ratio | $0.17 | $0.14 | $0.14 | $0.14 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.44B | $6.41B | $5.84B | $5.75B |
| Operating Expenses | $6.44B | $6.41B | $5.84B | $5.75B |
| Total Costs & Expenses | $66.67B | $67.87B | $63.08B | $57.30B |
| Interest Income | $21.00M | $0.00 | $6.00M | $28.00M |
| Interest Expense | $465.00M | $0.00 | $473.00M | $468.00M |
| Depreciation & Amortization | $2.90B | $2.64B | $2.62B | $2.62B |
| EBITDA | $8.99B | $6.20B | $5.72B | $5.90B |
| EBITDA Ratio | $0.12 | $0.09 | $0.09 | $0.10 |
| Operating Income | $5.98B | $3.60B | $3.79B | $2.68B |
| Operating Income Ratio | $0.08 | $0.05 | $0.06 | $0.04 |
| Other Income/Expenses (Net) | -$356.00M | $1.72B | -$1.37B | $169.00M |
| Income Before Tax | $5.62B | $5.32B | $2.42B | $2.85B |
| Income Before Tax Ratio | $0.08 | $0.07 | $0.04 | $0.05 |
| Income Tax Expense | $900.00M | $2.12B | $1.61B | $926.00M |
| Net Income | $4.71B | $3.19B | $947.00M | $1.92B |
| Net Income Ratio | $0.06 | $0.04 | $0.01 | $0.03 |
| EPS | $50.67 | $34.36 | $10.14 | $20.50 |
| Diluted EPS | $50.67 | $34.36 | $10.14 | $20.50 |
| Weighted Avg Shares Outstanding | $92.97M | $92.81M | $93.50M | $93.50M |
| Weighted Avg Shares Outstanding (Diluted) | $92.97M | $92.81M | $93.50M | $93.50M |
The company's financials show resilient growth, with revenue advancing from $59.98B in Q1 2024 to $72.65B in Q4 2024. Gross profit remained healthy with margins at 17% in Q4 2024 compared to 14% in Q1 2024. Operating income hit $5.98B last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $8.99B. Net income rose to $4.71B, while earnings per share reached $50.67. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan